These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1353244)

  • 1. Supersensitivity of sigma receptors after repeated administration of cocaine.
    Ujike H; Tsuchida K; Akiyama K; Otsuki S
    Life Sci; 1992; 51(6):PL31-6. PubMed ID: 1353244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment.
    Ujike H; Okumura K; Zushi Y; Akiyama K; Otsuki S
    Eur J Pharmacol; 1992 Feb; 211(3):323-8. PubMed ID: 1352252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization.
    Ujike H; Kanzaki A; Okumura K; Akiyama K; Otsuki S
    Life Sci; 1992; 50(16):PL129-34. PubMed ID: 1313134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characteristics of hyperambulation induced by the sigma ligand (+)-3-PPP in rats.
    Hirotsu I; Koyama M; Honbo N; Ohno T
    Jpn J Pharmacol; 1994 May; 65(1):1-7. PubMed ID: 7916383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective sigma receptor agonist and antagonist affect dopamine neuronal activity.
    Steinfels GF; Tam SW
    Eur J Pharmacol; 1989 Apr; 163(1):167-70. PubMed ID: 2568265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sigma Receptor antagonists block the development of sensitization to cocaine.
    Ujike H; Kuroda S; Otsuki S
    Eur J Pharmacol; 1996 Jan; 296(2):123-8. PubMed ID: 8838447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma ligand-induced emesis in the pigeon.
    Hudzik TJ
    Pharmacol Biochem Behav; 1992 Jan; 41(1):215-7. PubMed ID: 1347173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor.
    Earley B; Burke M; Leonard BE; Gouret CJ; Junien JL
    Brain Res; 1991 Apr; 546(2):282-6. PubMed ID: 1676927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple vascular effects of sigma and PCP ligands: inhibition of amine uptake and contractile responses.
    Massamiri T; Duckles SP
    J Pharmacol Exp Ther; 1990 Apr; 253(1):124-9. PubMed ID: 2158542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brain.
    Contreras PC; Bremer ME; Rao TS
    Life Sci; 1990; 47(22):PL133-7. PubMed ID: 1980329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes.
    Karbon EW; Naper K; Pontecorvo MJ
    Eur J Pharmacol; 1991 Jan; 193(1):21-7. PubMed ID: 1675607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMY-14802 reverses the reduction of striatal dopamine release induced by (+)-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine.
    Kanzaki A; Okumura K; Ujike H; Tsuchida K; Akiyama K; Otsuki S
    J Neural Transm Gen Sect; 1992; 90(2):137-44. PubMed ID: 1361127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine binding to sigma receptors in mouse brain in vivo.
    Koe BK; Burkhart CA; Lebel LA
    Eur J Pharmacol; 1989 Feb; 161(2-3):263-6. PubMed ID: 2566491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of sigma receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple sigma binding sites.
    Itzhak Y; Stein I
    Brain Res; 1991 Dec; 566(1-2):166-72. PubMed ID: 1667608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma-receptors: implication for the control of neuronal activity of nigral dopamine-containing neurons.
    Engberg G; Wikström H
    Eur J Pharmacol; 1991 Aug; 201(2-3):199-202. PubMed ID: 1686758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats.
    Kitaichi K; Noda Y; Hasegawa T; Furukawa H; Nabeshima T
    Eur J Pharmacol; 1996 Dec; 318(2-3):205-11. PubMed ID: 9016907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DTG and (+)-3-PPP inhibit a ligand-activated hyperpolarization in mammalian neurons.
    Bobker DH; Shen KZ; Surprenant A; Williams JT
    J Pharmacol Exp Ther; 1989 Dec; 251(3):840-5. PubMed ID: 2574744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of sigma-receptors: high- and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-Di(2-tolyl)guanidine.
    Beart PM; O'Shea RD; Manallack DT
    J Neurochem; 1989 Sep; 53(3):779-88. PubMed ID: 2569504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
    Ericson H; Ross SB
    Eur J Pharmacol; 1992 Jun; 226(2):157-61. PubMed ID: 1353452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.